cerebellum GABA level in Parkinson's disease

The impact of High-Definition transcranial direct current stimulation on depression, cognitive function and cerebellum GABA level in Parkinson's disease patients based on MEGA-PRESS analysis

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400093362

Enrollment

Unknown

Registered

2024-12-03

Start date

2024-12-31

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

PD group:Cross-sectional study, without intervention measures

Control group:Cross-sectional study, without intervention measures

Eligibility

Sex/Gender

All

Age

40 Years to 85 Years

Inclusion criteria

Inclusion criteria: ? Ages between 40 and 85, both genders are welcome. ? Primary Parkinson's disease that meets the diagnostic criteria for Parkinson's disease in China (2016 edition). ? Consent and sign the informed consent form to participate in this study.

Exclusion criteria

Exclusion criteria: ? Pacemaker implantees, individuals who cannot remove various metal devices, those with metal clips left in the body post-surgery, and those with claustrophobia or other conditions that prevent MRI examination; ? History of alcohol or drug abuse.

Design outcomes

Primary

Measure	Time frame
the level of GABA in the cerebellum;	—

Countries

China

Contacts

Public ContactChen weiguan

Nantong First People's Hospital

chenwg1982@163.com+86 138 1470 3625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026